Active Surveillance for Patients with Low-Risk Localized Prostate Cancer

For selected patients, this alternative to radical prostatectomy or radiation therapy is recommended.

Sponsoring Organization: American Society of Clinical Oncology (ASCO)

Target Audience: Oncologists, urologists, primary care physicians

Background

Active surveillance (AS) is used increasingly as an alternative to immediate treatment (e.g., radical prostatectomy, radiation therapy) for patients with low-risk localized prostate cancer. Recently, Cancer Care Ontario published a guideline entitled “Active Surveillance for the Management of Localized Prostate Cancer” (Can Urol Assoc J 2015; 9:171). ASCO now has formally endorsed most recommendations in that guideline.

Key Recommendations

AS, rather than immediate surgery or radiotherapy, is the recommended strategy for most patients with low-risk localized prostate cancer (Gleason score, ≤6). Howeve…

Reviewing Author

Allan S. Brett, MD

Disclosures

Nothing to disclose